Emilia Janiszewska-Rogoza

Szczecin, ZP 71252, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Copper and Zinc Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism and Psoriasis Disease.

Copper and Zinc Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism and Psoriasis Disease.

Journal: Biomedicines
Published: January 30, 2025

Selenium and Arsenic Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism, and Psoriasis Disease.

Selenium and Arsenic Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism, and Psoriasis Disease.

Journal: Biomedicines
Published: April 04, 2024

Serum Iron Level and 10-Year Survival after Melanoma.

Serum Iron Level and 10-Year Survival after Melanoma.

Journal: Biomedicines
Published: October 20, 2022

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Journal: Cancers
Published: October 11, 2021

Serum Selenium Level and 10-Year Survival after Melanoma.

Serum Selenium Level and 10-Year Survival after Melanoma.

Journal: Biomedicines
Published: July 20, 2021

Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population.

Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: September 25, 2020

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland.

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland.

Journal: Cancers
Published: July 16, 2020

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.

Journal: Breast cancer (Tokyo, Japan)
Published: April 25, 2020

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population.

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population.

Journal: PloS one
Published: June 08, 2018
Showing 1-9 of 9

Last Updated: 09/26/2026